Aggregated
64% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Roth Capital
A Roth Capital analyst with 24 tracked ratings spanning 16 distinct tickers has a 61.5% success rate on the captured sample, focusing on the sectors covered by both sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| CING | 2026-03-23 | buy | $14.00 | Aggregated |
| CRVO | 2026-03-18 | buy | $11.00 | Aggregated |
| NRSN | 2026-03-10 | buy | $3.00 | Aggregated |
| CING | 2025-11-19 | buy | $16.00 | Aggregated |
| CINGCINGULATE INC | 2025-11-19 | unknown | $16.00 | Aggregated |
| PYPD | 2025-11-13 | buy | $9.00 | Aggregated |
| PYPDPOLYPID LTD | 2025-11-13 | unknown | $9.00 | Aggregated |
| CAPR | 2025-11-12 | buy | $13.00 | Aggregated |
| CAPRCAPRICOR THERAPEUTICS INC | 2025-11-12 | unknown | $13.00 | Aggregated |
| CING | 2025-10-15 | buy | $17.00 | Aggregated |
| CINGCINGULATE INC | 2025-10-15 | unknown | $17.00 | Aggregated |
| RNA | 2025-09-17 | buy | $62.00 | Aggregated |
| RNAAVIDITY BIOSCIENCES INC | 2025-09-17 | unknown | $62.00 | Aggregated |
| RVPH | 2025-08-18 | buy | $3.00 | Aggregated |
| RVPHREVIVA PHARMACEUTICALS HOLDINGS INC. | 2025-08-18 | unknown | $3.00 | Aggregated |
| GANX | 2025-08-13 | buy | $6.00 | Aggregated |
| GANXGAIN THERAPEUTICS INC | 2025-08-13 | unknown | $6.00 | Aggregated |
| CRVO | 2025-08-12 | buy | $16.00 | Aggregated |
| CRVOCERVOMED INC | 2025-08-12 | unknown | $16.00 | Aggregated |
| CAPR | 2025-07-14 | buy | $12.00 | Aggregated |
| PYPD | 2025-06-18 | buy | $9.00 | Aggregated |
| VRNAVERONA PHARMA PLC - ADR | 2025-06-18 | unknown | $116.00 | Aggregated |
| CAPR | 2025-06-17 | buy | $31.00 | Aggregated |
| PYPD | 2025-06-05 | buy | $9.00 | Aggregated |
| CING | 2025-05-19 | buy | $11.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| CING | 4 | 2026-03-23 | Aggregated |
| CRVO | 2 | 2026-03-18 | Aggregated |
| NRSN | 1 | 2026-03-10 | Aggregated |
| CINGCINGULATE INC | 2 | 2025-11-19 | Aggregated |
| PYPD | 3 | 2025-11-13 | Aggregated |
| PYPDPOLYPID LTD | 1 | 2025-11-13 | Aggregated |
| CAPR | 3 | 2025-11-12 | Aggregated |
| CAPRCAPRICOR THERAPEUTICS INC | 1 | 2025-11-12 | Aggregated |
| RNA | 1 | 2025-09-17 | Aggregated |
| RNAAVIDITY BIOSCIENCES INC | 1 | 2025-09-17 | Aggregated |
| RVPH | 1 | 2025-08-18 | Aggregated |
| RVPHREVIVA PHARMACEUTICALS HOLDINGS INC. | 1 | 2025-08-18 | Aggregated |
| GANX | 1 | 2025-08-13 | Aggregated |
| GANXGAIN THERAPEUTICS INC | 1 | 2025-08-13 | Aggregated |
| CRVOCERVOMED INC | 1 | 2025-08-12 | Aggregated |
| VRNAVERONA PHARMA PLC - ADR | 1 | 2025-06-18 | Aggregated |